ACAD

ACADIAA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

earningsSentiment +72

Source

External coverage

Decided

2026-05-06

ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

The payload explicitly identifies ACAD as the issuer, and the title/summary cite a Q4 earnings beat with revenue growth driven by Nuplazid and Daybue.

View event details

Sentiment decomposition

0.0

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for ACAD. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-05-06 • Updated scheduledSource: News desk